Bibliography
- Cuatrecasas P . Interview with Pedro Cuatrecasas.Nat. Rev. Drug Discov.8, 446 (2009).
- Gopinathan S , NouraldeenA, WilsonAGE. Development and application of a high throughput formulation screening strategy in drug discovery.Curr. Drug Discovery Tech. (2009) (In Press).
- Sastry SV , NyshadhamJR, FixJA. Recent technological advances in oral drug delivery – a review.Pharmaceut. Sci. Tech. Today3, 138–145 (2000).
- Gupta H , BhandariD, SharmaA. Recent trends in oral drug delivery: a review.Recent Pat. Drug Deliv. Formulation3, 162–173 (2009).
- Singh BN , KimKH. Drug delivery: oral route. In: Encyclopedia of Pharmaceutical Technology (3rd Edition). Informa Healthcare, London, UK 1242–1265 (2006).
- Maas J , KammW, HauckG. An integrated early formulation strategy – from hit evaluation to preclinical candidate profiling.Eur. J. Pharm. Biopharm.66, 1–10 (2007).
- Neervannan N . Preclinical formulations for discovery and toxicology: physicochemical challenges.Expert Opin. Drug Metabol. Toxicol.2, 715–731 (2006).
- Li P , ZhaoL. Developing early formulations: practice and perspective.Int. J. Pharm.341, 1–19 (2007).
- Venkatesh S , LipperRA. Role of the development scientist in compound lead selection and optimization.J. Pharm. Sci.89, 145–154 (2000).
- Lee YC , ZocharskiPD, SamasB. An intravenous formulation decision tree for discovery compound formulation development.Int. J. Pharm.253, 111–119 (2003).
- Gonzalez RCB , HuwylerJ, WalterI, MountfieldR, BittnerB. Improved oral bioavailability of cyclosporin A in male Wistar rats: comparison of a Solutol HS 15 containing self-dispersing formulation and a microsuspension.Int. J. Pharm.245, 143–151 (2002).
- Klein S , WempeMF, ZoellerTet al. Improving glyburide solubility and dissolution by complexation with hydroxybutenyl-β-cyclodextrin. J. Pharm. Pharmacol. 61, 23–30 (2009).
- Lipinski CA , LombardoF, DominyBW, FeeneyPJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings.Adv. Drug Delivery Rev.46, 3–26 (2001).
- Gould S , ScottRC. 2-hydroxypropyl-b-cyclodextrin (HP-b-CD): a toxicology review.Food Chem. Toxicol.43, 1451–1459 (2005).
- Gad SC , CassidyCD, AubertN, SpainhourB, RobbeH. Nonclinical vehicle use in studies by multiple routes in multiple species.Int. J. Toxicol.25, 499–521 (2006).
- Pestel S , Martin H-J, Maier G-M, Guth B. Effect of commonly used vehicles on gastrointestinal, renal, and liver function in rats. J. Pharmacol. Toxicol. Methods54, 200–214 (2006).
- Strickley G . Solubilizing excipients in oral and injectable formulations.Pharm. Res.21, 201–230 (2004).
- Kola I , LandisJ. Can the pharmaceutical industry reduce attrition rates?Nat. Rev. Drug Discov.3(8), 711–715 (2004).